Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

BHVN Relative to the S&P 500

BHVN Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Biohaven Ltd. (NYSE:BHVN) seasonal charts above shows that a Buy Date of August 12 and a Sell Date of November 5 has resulted in a geometric average return of 48.04% above the benchmark rate of the S&P 500 Total Return Index over the past 7 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is an excellent rate of success and the return slightly outperforms the relative buy-and-hold performance of the stock over the past 7 years by an average of 0.58% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 7 years of data is available for shares of BHVN, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology.? Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

To download BHVN seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: BHVN